Related Experiment Video
Updated: Mar 1, 2026
06:58
Highlighting and Reducing the Impact of Negative Aging Stereotypes During Older Adults' Cognitive Testing
Published on: January 24, 2020
7.9K
Managing depression and anxiety in the elderly patient
1Department of Psychiatry, Royal Free and University College Medical School, Wolfson Building, 48 Riding House Street, London W1N 8AA, UK. c.katona@ucl.ac.uk
Summary
Late-life depression is often overlooked but treatable with antidepressants. Selective serotonin re-uptake inhibitors (SSRIs) offer a safer option for elderly patients due to fewer side effects.
Area of Science:
- Geriatric Psychiatry
- Clinical Pharmacology
Background:
- Late-life depression is under-recognized and undertreated, frequently mistaken as a normal part of aging.
- Differentiating depression from comorbid anxiety and cognitive disorders in the elderly presents a clinical challenge.
Purpose of the Study:
- To review the efficacy and safety of antidepressant treatments for late-life depression.
- To discuss the suitability of selective serotonin re-uptake inhibitors (SSRIs) for older adults.
Main Methods:
- Review of existing literature on antidepressant efficacy and tolerability in elderly populations.
- Comparative analysis of tricyclic antidepressants (TCAs) versus SSRIs in geriatric depression.
Main Results:
- Antidepressants demonstrate comparable efficacy in acute and maintenance treatment for both elderly and younger adults.
- TCAs may be difficult to manage in the elderly due to side effects, hindering therapeutic level attainment.
- SSRIs present a more favorable safety and tolerability profile for older patients, who are more susceptible to adverse effects.
Conclusions:
- SSRIs are a suitable treatment option for late-life depression, considering their safety profile.
- Selection of an SSRI should account for its pharmacokinetic properties and impact on prevalent elderly comorbidities like anxiety, dementia, and cardiovascular disease.
Related Concept Videos
01:15Drug Dosing: Geriatric Patients
328
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
328
01:00Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution
302
Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are...
302
01:27Pharmacodynamics in Geriatric Patients: Effects of Age
287
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
287
01:23Antidepressant Drugs: MAOIs and Other Agents
1.1K
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
1.1K
01:28Drug Therapy
333
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
333
01:26Anxiolytic Drugs: Overview
1.3K
Anxiolytic drugs are vital in managing anxiety disorders by effectively alleviating symptoms such as excessive fear, tachycardia, and tremors. There are several classes of anxiolytic medications, each with unique mechanisms of action and potential side effects.
Primary Types of Anxiolytic Drugs
1. Benzodiazepines:
Benzodiazepines bind to the GABA-A receptor in the brain, enhancing GABA's interaction. This action reduces neurotransmission, effectively blocking anxiety-associated limbic...
Primary Types of Anxiolytic Drugs
1. Benzodiazepines:
Benzodiazepines bind to the GABA-A receptor in the brain, enhancing GABA's interaction. This action reduces neurotransmission, effectively blocking anxiety-associated limbic...
1.3K